Irisin is a newly discovered exercise-mediated myokine which regulates energy metabolism and has been the subject of much recent research. Irisin plays an important role in metabolic diseases making it a potential new target to combat obesity and its associated disorders, such as T2DM. However, the results of several recent studies investigating the effects of irisin have been controversial. The present review will introduce the discovery of irisin, the role of irisin in metabolic disorders, possible mechanisms, and unanswered questions for future research.
CITATION STYLE
Chen, J. Q., Huang, Y. Y., Gusdon, A. M., & Qu, S. (2015, January 14). Irisin: A new molecular marker and target in metabolic disorder. Lipids in Health and Disease. BioMed Central Ltd. https://doi.org/10.1186/1476-511X-14-2
Mendeley helps you to discover research relevant for your work.